Related Experiment Video
Updated: Jun 20, 2026

Adoptive Immunotherapy of iNKT Cells in Glucose-6-Phosphate Isomerase (G6PI)-Induced RA Mice
Published on: January 31, 2020
Low levels of soluble CD1d protein alters NKT cell function in patients with rheumatoid arthritis
Seiji Segawa1, Daisuke Goto, Yohei Yoshiga
1Division of Clinical Immunology, Doctoral Program in Clinical Sciences, Graduate School of Comprehensive Human Sciences, University of Tsukuba, Japan.
Abstract:
CD1d molecules on the cell surface play a critical role in the presentation of glycolipid antigens to natural killer T (NKT) cells. We previously showed that the human CD1d gene has 8 splice variants, one of which is a soluble form lacking the beta2-m and transmembrane domains. This study focused on soluble CD1d (sCD1d) by generating recombinant sCD1d proteins and assaying them in plasma using a newly established ELISA method. The amount of sCD1d proteins in plasma was significantly decreased in rheumatoid arthritis (RA) patients (55.2+/-13.3 years, mean +/-SD) compared with healthy donors (31.2+/-7.4 years). Plasma sCD1d protein levels correlated with the number of NKT cells (TCR V alpha 24+ V beta 11+CD3+) in peripheral blood mononuclear cells (r(2)=0.061). Furthermore, sCD1d proteins induced IFN-gamma production from NKT cells, but neither IL-4 nor IL-10. These findings suggest that the low plasma levels of sCD1d protein in RA patients reduce the number and thus activation of peripheral NKT cells. It is therefore hypothesized that sCD1d stimulates NKT cells and low plasma sCD1d levels in RA reflect a pathogenic mechanism associated with a decrease in NKT cells.
Insights
Soluble CD1d (sCD1d) proteins are crucial for natural killer T (NKT) cell activation. Rheumatoid arthritis patients exhibit lower plasma sCD1d levels, potentially contributing to reduced NKT cell numbers and function.
Area of Science:
- Immunology
- Molecular Biology
Background:
- CD1d molecules present glycolipid antigens to natural killer T (NKT) cells.
- Eight human CD1d splice variants exist, including a soluble form (sCD1d).
Purpose of the Study:
- To investigate the role of soluble CD1d (sCD1d) in rheumatoid arthritis (RA).
- To quantify plasma sCD1d levels and their correlation with NKT cells in RA patients.
Main Methods:
- Generation of recombinant sCD1d proteins.
- Quantification of plasma sCD1d using a newly established ELISA.
- Analysis of NKT cell populations (TCR V alpha 24+ V beta 11+CD3+) in peripheral blood mononuclear cells.
- Assay of sCD1d-induced cytokine production (IFN-gamma, IL-4, IL-10) from NKT cells.
Main Results:
- Plasma sCD1d protein levels were significantly decreased in RA patients compared to healthy donors.
- Plasma sCD1d levels correlated with the number of peripheral NKT cells.
- sCD1d induced IFN-gamma production from NKT cells, but not IL-4 or IL-10.
Conclusions:
- Low plasma sCD1d levels in RA patients may lead to reduced NKT cell numbers and activation.
- sCD1d stimulates NKT cells, suggesting a role in RA pathogenesis.
- Decreased sCD1d levels in RA could be a pathogenic mechanism linked to NKT cell reduction.
Related Concept Videos
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Inflammatory Bowel Disease III: Crohn's Disease
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR activation may...

